INHIBITION OF PCSK9 AFFECTS SERUM LIPOPROTEIN FUNCTIONS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

被引：0

作者：

Palumbo, M. ^{[1
]}

Adorni, M. P. ^{[2
]}

Zimetti, F. ^{[1
]}

Pavanello, C. ^{[3
]}

Giammanco, A. ^{[4
]}

Cefalu, A. B. ^{[4
]}

Noto, D. ^{[4
]}

Piro, S. ^{[5
]}

Di Pino, A. ^{[5
]}

Averna, M. ^{[4
]}

Calabresi, L. ^{[3
]}

Bernini, F. ^{[1
]}

Purrello, F. ^{[5
]}

Scicali, R. ^{[5
]}

机构：

[1] Univ Parma, Dept Food & Drug, Parma, Italy

[2] Univ Parma, Dept Med & Surg, Unit Neurosci, Parma, Italy

[3] Univ Milan, Pharmacol & Biomol Sci, Milan, Italy

[4] Univ Palermo, Dept Hlth Promot Mother & Child Care Internal Med, Palermo, Italy

[5] ARNAS GARIBALDI NESIMA, Dept Med, Catania, Italy

来源：

ATHEROSCLEROSIS | 2022年 / 355卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

EP222

引用

页码：E157 / E157

页数：1

共 50 条

[11] SCREENING OF PCSK9 GENE IN INDIAN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
Reddy, L. L.
Ponde, C. K.
Rajani, R. M.
Pillai, S.
Dalal, R. J.
Vanjani, C. V.
Dalal, J.
Ashavaid, T. F.
ATHEROSCLEROSIS, 2019, 287 : E212 - E212
[12] PCSK9 INHIBITOR UTILIZATION IN FAMILIAL HYPERCHOLESTEROLEMIA
Jackson, Candace
Deng, Yihong
Yao, Xiaoxi
Van Houten, Holly
Shah, Nilay
Kopecky, Stephen
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1873 - 1873
[13] PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study
Daniels, Stephen
Caprio, Sonia
Chaudhari, Umesh
Manvelian, Garen
Baccara-Dinet, Marie T.
Brunet, Aurelie
Scemama, Michel
Loizeau, Virginie
Bruckert, Eric
JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (03) : 322 - +
[14] PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia
Alonso, Rodrigo
Mata, Pedro
Muniz, Ovidio
Fuentes-Jimenez, Francisco
Diaz, Jose Luis
Zambon, Daniel
Tomas, Marta
Martin, Cesar
Moyon, Thomas
Croyal, Mikael
Thedrez, Aurelie
Lambert, Gilles
ATHEROSCLEROSIS, 2016, 254 : 249 - 253
[15] Inhibition of PCSK9 in familial hypercholesterolaemia
Sijbrands, Eric J. G.
LANCET, 2012, 380 (9836): : 6 - 7
[16] A Decision Aid for the Use of PCSK9 Inhibitors in Patients With Familial Hypercholesterolemia
Farwati, Medhat
Shaw, Kevin
Hargraves, Ian G.
Montori, Victor M.
Kullo, Iftikhar J.
CIRCULATION, 2018, 138
[17] PCSK9 inhibition for autosomal recessive hypercholesterolemia
Chemello, Kevin
Martin, Cesar
Lambert, Gilles
ATHEROSCLEROSIS, 2019, 284 : 209 - 211
[18] PCSK9 inhibitors in familial hypercholesterolemia: What is the evidence?
Paquette, Martine
Hegele, Robert A.
Baass, Alexis
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (05) : 1106 - 1108
[19] PCSK9 in South African Variants of Familial Hypercholesterolemia
Getz, Godfrey S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) : 2374 - 2375
[20] A CASE FOR PCSK9 INHIBITORS IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
Arnold, Claire
Stephenson, Christopher
JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S574 - S575

← 1 2 3 4 5 →